Rainusso, Nino

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Ahmed, N., Brawley, V. S., Hegde, M., Robertson, C., Ghazi, A., Gerken, C., Liu, E., Dakhova, O., Ashoori, A., Corder, A., et al. (2015) · Journal of Clinical Oncology

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 1,004

Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma

Rainusso, N., Brawley, V. S., Ghazi, A., Hicks, M. J., Gottschalk, S., Rosen, J. M., & Ahmed, N. (2012) · Cancer Gene Therapy

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 114

Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma

Nomura, M., Rainusso, N., Lee, Y.-C., Dawson, B., Coarfa, C., Han, R., Larson, J. L., Shuck, R., Kurenbekova, L., & Yustein, J. T. (2019) · JNCI: Journal of the National Cancer Institute

Sarcoma Diagnosis and TreatmentWnt/β-catenin signaling in development and cancer

Cited by 99

Pediatric Solid Tumors in Children and Adolescents: An Overview

Allen-Rhoades, W., Whittle, S. B., & Rainusso, N. (2018) · Pediatrics In Review

Sarcoma Diagnosis and TreatmentTesticular diseases and treatments

Cited by 24